# Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order

- Link: https://www.thailand-business-news.com/pr-news/metabolon-verus-metabolomics-profiling-kit-now-available-to-order
- Published: 2026-09-08T20:00:00+07:00
- Author: PR Newswire

|   |

_A successful multi-site ring trial and early access program demonstrate the reproducibility,
scalability, and biological insight of the Metabolon Verus™ Metabolomics Profiling
Kit across laboratories worldwide_

MORRISVILLE, N.C., Sept. 8, 2026 /PRNewswire/ — Metabolon, Inc., the global leader
in providing metabolomics solutions advancing a wide variety of life science research,
diagnostic, therapeutic development, and precision medicine applications, today 
announced that the Metabolon Verus™ Metabolomics Profiling Kit is now available 
to order, moving Metabolon’s first metabolomics kit from early access into full 
commercial availability.

First announced in May 2026 at the 74th ASMS Conference on Mass Spectrometry, the
Metabolon Verus™ Metabolomics Profiling Kit is designed to extend Metabolon’s market-
leading capabilities beyond centralized services and into laboratories worldwide,
combining sample preparation, quality control, automated compound annotation, and
access to Metabolon’s Integrated Bioinformatics Platform (IBP) in a single standardized
workflow.

During the Early Access Program, 10 laboratories across five countries ran the Metabolon
Verus™ Metabolomics Profiling Kit on their own instruments, applying it to studies
spanning microbiome research, allogeneic stem cell transplantation, delirium, pulmonary
fibrosis, and traumatic brain injury. Their hands-on experience across these applications
drove the refinements to training, documentation, and customer support.

Metabolon also completed a ring trial for the Metabolon Verus™ Metabolomics Profiling
Kit across eight independent laboratories worldwide, using a fed-fasted study of
plasma and sex-based signatures in urine samples. In addition to comparisons between
labs, results from each site were benchmarked against an accurate truth dataset 
and two targeted panels with 8-point calibration for 27 analytes. Metabolon generated
the accurate truth dataset by running the same fed-fasted samples at its headquarters
using the same kit methods, with results meticulously curated by its expert scientists.
Across all eight sites, labs detected an average of 735 metabolites per plasma sample
set, with 89% metabolite overlap between labs and an average of 90 pathways represented
per set. Metabolite abundance correlated with the accurate truth dataset at a median
coefficient of 0.91, and fold-change differences between fed and fasted states and
significant metabolites were strongly conserved in each of the eight labs.

"Reproducibility remains one of the biggest barriers to scaling metabolomics," said
Dr. Annie Evans, Head of Core R&D at Metabolon, who presented the ring trial results
at the Metabolomics Society meeting in Buenos Aires in June 2026. "What stood out
was not only how well the ring trial readout from the labs matched in terms of metabolite
count and number of significant metabolites, but also how well the fold-change in
response between fed-fasted correlated. It is an amazing result, really emphasizing
reproducibility of the workflow and the quality of the analytical pipeline that 
can drive the results."

As multiomics analysis becomes more established across academic research, CROs, 
biotechs, and pharmaceutical companies, sponsors still face the same practical obstacle:
results from each omics layer arrive on different timelines and in different formats,
so joint analysis requires reconciling data across platforms before the science 
can even start. The Metabolon Verus™ Metabolomics Profiling Kit is designed to close
that gap. Transcriptomics, proteomics, metagenomics, and clinical data can be seamlessly
integrated into a single platform to provide a more holistic view, enabling a deeper
understanding of the complex biological system under study. Because the kit returns
results in five days, it offers the flexibility to align with sequencing platform
turnaround times or other omics methods, giving researchers greater efficiency, 
scalability, and control over their timelines. The result is a genuine multiomics
readout, rather than several separately timed datasets stitched together after the
fact, that accelerates multiomics research and supports longitudinal, multi-cohort
studies for CROs, biotechs, and pharma sponsors.

"Making Metabolon Verus available to order is an important milestone for Metabolon
and for the broader metabolomics community. It’s our first decentralized product,
encapsulating 25 years of experience," said Ro Hastie, CEO of Metabolon. "We set
out to make high-quality metabolomics more accessible without compromising the scientific
rigor, reproducibility, or biological insight researchers expect from Metabolon.
The results of our early access program and ring trial give us strong confidence
that Metabolon Verus delivers on that promise in laboratories around the world."

**The Metabolon Verus™ Metabolomics Profiling Kit delivers:**

 ◦ Consistent, comparable data everywhere it runs, through standardized sample preparation
   and acquisition workflows that eliminate site-to-site variability.
 ◦ Confidence in the data before analysis even starts, with built-in quality assurance
   and quality control that ensure every dataset meets Metabolon’s minimum quality
   threshold.
 ◦ Just days from raw data to processed metabolite results, through automated data
   processing and compound identification that remove the manual curation bottleneck.
 ◦ Enough biological breadth to answer more than one question, from a reference 
   library of more than 1,500 metabolites across 100 biochemical sub-pathways spanning
   metabolic disease, exposome, the microbiome, kidney and liver function, and beyond.
 ◦ Plug metabolomics into your multiomics portfolio without heavy development or
   informatics investment, adding Metabolon-standard metabolomics for deeper mechanism-
   of-action, safety, and translational insights.
 ◦ A path from data to decision with Metabolon’s intuitive Integrated Bioinformatics
   Platform for statistical analysis, pathway mapping, visualization, collaboration,
   and multiomics integration.
 ◦ A faster route to running metabolomics in-house, backed by training and scientific
   support that help laboratories establish and scale metabolomics capabilities 
   without months of method development.

For more than 25 years, researchers have sent samples to Metabolon to access the
company’s metabolomics technology and expertise. With the Metabolon Verus™ Metabolomics
Profiling Kit, laboratories can now run a standardized Metabolon workflow in-house
while remaining connected to the company’s data-processing infrastructure, compound
annotation capabilities, bioinformatics tools, and scientific expertise.

The Metabolon Verus™ Metabolomics Profiling Kit is now available to order in North
American markets, with international availability in early 2027.  To learn more 
or place an order, visit:
[https://www.metabolon.com/metabolon-verus-metabolomics-profiling-kit/](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4756945-1&h=3852763286&u=https%3A%2F%2Fwww.metabolon.com%2Fmetabolon-verus-metabolomics-profiling-kit%2F&a=https%3A%2F%2Fwww.metabolon.com%2Fmetabolon-verus-metabolomics-profiling-kit%2F)

**About MetabolomicsMetabolomics, the large-scale study of all small molecules in
a biological system, is the only omics technology that provides a complete current-
state functional readout of a biological system. Metabolomics helps researchers 
see beyond individual genetic variation, capturing the combined impact of genetic
and external factors, such as drugs, diet, lifestyle, and the microbiome, on human
health. By measuring thousands of discrete chemical signals that form biological
pathways in the body, metabolomics can reveal important biomarkers, enabling a better
understanding of a drug’s mechanism of action, pharmacodynamics, and safety profile,
as well as individual responses to therapy.

**About Metabolon[Metabolon](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4756945-1&h=297069036&u=http%3A%2F%2Fwww.metabolon.com%2F&a=Metabolon),
Inc. is the global leader in metabolomics, with a mission to deliver biochemical
data and insights that expand and accelerate the impact of life sciences research
and complement other ‘omics’ technologies. With more than 25 years of metabolomics
leadership, 15,000+ projects, 4,000+ publications, and ISO 9001:2015, CLIA, and 
CAP certifications. Metabolon’s Global Discovery Panel is powered by the world’s
largest proprietary metabolomics reference library, while Metabolon’s expanding 
portfolio of solutions enables researchers to access Metabolon-standard metabolomics
through both centralized services and in-house workflows. The Metabolon Verus™ Metabolomics
Profiling Kit extends Metabolon’s validated methods into laboratories worldwide,
enabling researchers with LC-MS capabilities to generate standardized, reproducible
metabolomics data on-site through streamlined workflows, embedded quality controls,
automated compound annotation, and direct access to Metabolon’s Integrated Bioinformatics
Platform. Metabolon’s industry-leading data, translational science, and bioinformatics
expertise help customers and partners address some of the most challenging questions
in the life sciences, accelerating research and enhancing development success. The
company offers scalable, customizable metabolomics and multiomics solutions—from
discovery and targeted services to decentralized in-house metabolomics—that support
customer needs across academic research, biopharma, core facilities, and CROs, from
early discovery through clinical trials and product life-cycle management. For more
information, please visit [www.metabolon.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4756945-1&h=754536134&u=http%3A%2F%2Fwww.metabolon.com%2F&a=www.metabolon.com)
and follow us on [LinkedIn](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4756945-1&h=640553456&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F39312&a=LinkedIn)
and [X](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4756945-1&h=2193634987&u=https%3A%2F%2Ftwitter.com%2FMetabolon&a=X).

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order ](http://www.prnasia.com/story/archive/5031009_AE31009_0?rand=184833)
